Andreia Peixoto

ORCID: 0000-0001-9514-0775 · 1 paper in corpus · active 2021
2021
·doi:10.1101/2021.09.04.458979

Bladder cancer (BC) management demands the introduction of novel molecular targets for precision medicine. Cell surface glycoprotein CD44 has been widely studied as a potential biomarker of BC aggressiveness and cancer stem cells. However, …